BRPI0615394B8 - composições oftálmicas de cetotifeno estabilizadas e conservadas - Google Patents

composições oftálmicas de cetotifeno estabilizadas e conservadas

Info

Publication number
BRPI0615394B8
BRPI0615394B8 BRPI0615394A BRPI0615394A BRPI0615394B8 BR PI0615394 B8 BRPI0615394 B8 BR PI0615394B8 BR PI0615394 A BRPI0615394 A BR PI0615394A BR PI0615394 A BRPI0615394 A BR PI0615394A BR PI0615394 B8 BRPI0615394 B8 BR PI0615394B8
Authority
BR
Brazil
Prior art keywords
stabilized
ophthalmic compositions
preserved
hydrogen peroxide
ketotifen
Prior art date
Application number
BRPI0615394A
Other languages
English (en)
Inventor
Tsao Fu-Pao
P Wong Michelle
Fong Yen Shau
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0615394A2 publication Critical patent/BRPI0615394A2/pt
Publication of BRPI0615394B1 publication Critical patent/BRPI0615394B1/pt
Publication of BRPI0615394B8 publication Critical patent/BRPI0615394B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

composições oftálmicas de cetotifeno estabilizadas e conservadas. a presente invenção refere-se a composições oftálmicas com- preendendo cetotifeno e uma fonte de peróxido de hidrogênio, a dita fonte proporcionando uma quantidade de peróxido de hidrogênio de cerca de 0,001 a cerca de 0,1% (peso/volume) de peróxido de hidrogênio e a métodos para o tratamento e prevenção de conjuntivite alérgica mediante uso das composições aqui proporcionadas.
BRPI0615394A 2005-08-26 2006-08-24 composições oftálmicas de cetotifeno estabilizadas e conservadas BRPI0615394B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/212,959 2005-08-26
US11/212,959 US20070048389A1 (en) 2005-08-26 2005-08-26 Stabilized and preserved ketotifen ophthalmic compositions
PCT/US2006/033161 WO2007025092A2 (en) 2005-08-26 2006-08-24 Stabilized and preserved ketotifen ophthalmic compositions

Publications (3)

Publication Number Publication Date
BRPI0615394A2 BRPI0615394A2 (pt) 2011-05-17
BRPI0615394B1 BRPI0615394B1 (pt) 2020-05-19
BRPI0615394B8 true BRPI0615394B8 (pt) 2021-05-25

Family

ID=37441908

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0615394A BRPI0615394B8 (pt) 2005-08-26 2006-08-24 composições oftálmicas de cetotifeno estabilizadas e conservadas

Country Status (12)

Country Link
US (5) US20070048389A1 (pt)
EP (2) EP2343048B1 (pt)
JP (1) JP5111372B2 (pt)
KR (1) KR20080042144A (pt)
CN (1) CN101252911A (pt)
AU (2) AU2006282978A1 (pt)
BR (1) BRPI0615394B8 (pt)
CA (1) CA2619582C (pt)
ES (2) ES2592914T3 (pt)
MX (1) MX2008002654A (pt)
RU (1) RU2444361C2 (pt)
WO (1) WO2007025092A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2754996A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
WO2022006653A1 (en) * 2020-07-09 2022-01-13 Aliya Pharmaceuticals Inc. Anti-cancer activity of perborate salts

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614646A (en) * 1984-12-24 1986-09-30 The Dow Chemical Company Stabilization of peroxide systems in the presence of alkaline earth metal ions
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
EP0354186B1 (en) * 1988-08-04 1996-08-28 Ciba-Geigy Ag A method of preserving ophthalmic solutions and compositions therefor
DE4023086A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Methode zur behandlung von allergischer konjunktivitis
US5958957A (en) * 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6265444B1 (en) * 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
GB9824160D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
RU2266115C2 (ru) * 1999-09-13 2005-12-20 Бридж Фарма, Инк. Оптически активные изомеры кетотифена и их терапевтически активные метаболиты
US6531128B1 (en) * 2000-02-08 2003-03-11 Pharmacia Corporation Methods for treating glaucoma
ATE347557T1 (de) * 2000-03-23 2006-12-15 Takeda Pharmaceutical Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
TWI236377B (en) * 2000-09-28 2005-07-21 Novartis Ag Stabilized hydrogen peroxide solutions
RU2193403C1 (ru) * 2001-05-23 2002-11-27 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Глазные капли для лечения аллергических конъюнктивитов и кератоконъюнктивитов
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
AR038299A1 (es) * 2002-01-18 2005-01-12 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.
EP1534313B1 (en) * 2002-07-30 2012-10-17 Omeros Corporation Ophthalmologic irrigation solutions and method
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
JP4858306B2 (ja) 2006-07-27 2012-01-18 株式会社デンソー 熱電変換装置の製造方法

Also Published As

Publication number Publication date
BRPI0615394A2 (pt) 2011-05-17
MX2008002654A (es) 2008-03-18
BRPI0615394B1 (pt) 2020-05-19
US20130165480A1 (en) 2013-06-27
CN101252911A (zh) 2008-08-27
RU2444361C2 (ru) 2012-03-10
AU2006282978A1 (en) 2007-03-01
CA2619582C (en) 2014-11-18
ES2585777T3 (es) 2016-10-10
EP1922059A2 (en) 2008-05-21
KR20080042144A (ko) 2008-05-14
EP2343048B1 (en) 2016-05-04
ES2592914T3 (es) 2016-12-02
EP1922059B1 (en) 2016-06-22
WO2007025092A3 (en) 2007-09-27
US20120157496A1 (en) 2012-06-21
AU2010235948A1 (en) 2010-11-11
AU2010235948B2 (en) 2011-09-22
WO2007025092A2 (en) 2007-03-01
JP5111372B2 (ja) 2013-01-09
RU2008111065A (ru) 2009-10-10
EP2343048A3 (en) 2011-08-03
EP2343048A2 (en) 2011-07-13
US20110028516A1 (en) 2011-02-03
US20070048389A1 (en) 2007-03-01
CA2619582A1 (en) 2007-03-01
US20080207692A1 (en) 2008-08-28
JP2009506064A (ja) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1113212T1 (el) Σπειροκυκλικες ενωσεις ως αναστολεις αφυδρογονασης τυπου 1 11-βητα υδροξυλ στεροειδους
UY32714A (es) Mezclas fungicidas
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
BRPI0500704A (pt) composições de tratamento pessoal reidratáveis
MX2009009207A (es) Metodos y composiciones para normalizar las secreciones de glandulas meibomianas.
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
ATE547107T1 (de) Verwendung von selenhefe in der behandlung von alzheimers krankheit
GT200500179BA (es) Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados
CY1115188T1 (el) Πολυκυκλικες ετεροαρυλ-υποκατεστημενες τριαζολες χρησιμες ως αναστολεις του axl
NO20076515L (no) Hydantoinforbindelser
SV2009002900A (es) Diarilurea para el tratamiento de hipertension pulmonar
TNSN07222A1 (en) Nematicidal compositions
IN2012DN01345A (pt)
UA98658C2 (uk) Циклічні депсипептиди
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
UY32722A (es) Mezclas fungicidas
BRPI0516602A (pt) composto, e, composição farmacêutica
WO2010001119A3 (en) Use of glucosinolates from cruciferous plants in modifying extracellular signalling proteins
WO2008013983A3 (en) Opsin stabilizing compounds and methods of use
CY1111678T1 (el) Σταθεροποιημενες και διατηρημενες οφθαλμικες ενωσεις κετοτιφενης
ATE504598T1 (de) Cspcna-isoform-modifikationen und anwendungen davon
BRPI0615394B8 (pt) composições oftálmicas de cetotifeno estabilizadas e conservadas
DE602006014986D1 (de) Insulinotrope verbindungen und anwendungen davon

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/08/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF